Empirical Financial Services LLC d.b.a. Empirical Wealth Management Buys 495 Shares of The Clorox Company (NYSE:CLX)

Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its stake in The Clorox Company (NYSE:CLX) by 11.5% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 4,798 shares of the company’s stock after purchasing an additional 495 shares during the quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in The Clorox were worth $863,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in CLX. Champlain Investment Partners LLC bought a new stake in The Clorox in the first quarter valued at $200,453,000. Deutsche Bank AG boosted its holdings in The Clorox by 58.6% in the second quarter. Deutsche Bank AG now owns 879,345 shares of the company’s stock valued at $158,203,000 after acquiring an additional 325,024 shares in the last quarter. Nuveen Asset Management LLC boosted its holdings in The Clorox by 24.4% in the first quarter. Nuveen Asset Management LLC now owns 1,017,623 shares of the company’s stock valued at $196,280,000 after acquiring an additional 199,542 shares in the last quarter. Armistice Capital LLC boosted its holdings in shares of The Clorox by 316.7% during the 1st quarter. Armistice Capital LLC now owns 250,000 shares of the company’s stock valued at $48,220,000 after buying an additional 190,000 shares in the last quarter. Finally, Canada Pension Plan Investment Board boosted its holdings in shares of The Clorox by 677.8% during the 1st quarter. Canada Pension Plan Investment Board now owns 174,767 shares of the company’s stock valued at $33,709,000 after buying an additional 152,297 shares in the last quarter. Institutional investors and hedge funds own 77.77% of the company’s stock.

Shares of NYSE:CLX opened at $164.56 on Friday. The Clorox Company has a fifty-two week low of $159.32 and a fifty-two week high of $231.11. The business has a 50-day simple moving average of $170.62 and a two-hundred day simple moving average of $179.14. The company has a debt-to-equity ratio of 4.20, a quick ratio of 0.52 and a current ratio of 0.89. The firm has a market cap of $20.21 billion, a price-to-earnings ratio of 29.70, a price-to-earnings-growth ratio of 4.37 and a beta of 0.21.

The Clorox (NYSE:CLX) last issued its earnings results on Tuesday, August 3rd. The company reported $0.95 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.34). The Clorox had a return on equity of 94.42% and a net margin of 9.67%. The business had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.91 billion. During the same period last year, the firm posted $2.41 EPS. The Clorox’s quarterly revenue was down 9.1% compared to the same quarter last year. As a group, research analysts predict that The Clorox Company will post 5.54 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 10th. Shareholders of record on Wednesday, October 27th will be given a $1.16 dividend. This represents a $4.64 dividend on an annualized basis and a yield of 2.82%. The ex-dividend date of this dividend is Tuesday, October 26th. The Clorox’s dividend payout ratio (DPR) is 64.00%.

A number of analysts have recently commented on CLX shares. DA Davidson dropped their target price on shares of The Clorox from $177.00 to $145.00 and set a “neutral” rating on the stock in a report on Wednesday, August 4th. Wells Fargo & Company dropped their target price on shares of The Clorox from $170.00 to $155.00 and set an “underweight” rating on the stock in a report on Wednesday, August 4th. Argus cut shares of The Clorox from a “buy” rating to a “hold” rating in a report on Friday, September 3rd. UBS Group dropped their target price on shares of The Clorox from $166.00 to $154.00 and set a “sell” rating on the stock in a report on Wednesday, August 4th. They noted that the move was a valuation call. Finally, Credit Suisse Group dropped their target price on shares of The Clorox from $175.00 to $160.00 and set a “neutral” rating on the stock in a report on Wednesday, August 4th. Five research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $182.44.

The Clorox Profile

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Cleaning, Lifestyle, Household, and International. The Cleaning segment consists of laundry, home care, and professional products marketed and sold in the United States.

Recommended Story: Forex

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.